» Authors » Austin Campbell

Austin Campbell

Explore the profile of Austin Campbell including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 101
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell A, Chu L, Crittenden S, Sutton A, Boehler A
Am J Manag Care . 2024 Jun; 30(6):e172-e177. PMID: 38912931
Objectives: Chronic kidney disease (CKD) is a widely prevalent disease with heterogeneous disease progression. Prior study findings suggest that early referral to nephrologists can improve health outcomes for patients with...
2.
Vasconcelos Pereira G, Boudaud M, Wolter M, Alexander C, De Sciscio A, Grant E, et al.
Cell Host Microbe . 2024 Mar; 32(4):527-542.e9. PMID: 38513656
Inflammatory bowel diseases (IBDs) are chronic conditions characterized by periods of spontaneous intestinal inflammation and are increasing in industrialized populations. Combined with host genetics, diet and gut bacteria are thought...
3.
Kuffa P, Pickard J, Campbell A, Yamashita M, Schaus S, Martens E, et al.
Cell Host Microbe . 2023 Nov; 31(12):2007-2022.e12. PMID: 37967555
Exclusive enteral nutrition (EEN) with fiber-free diets is an effective steroid-sparing treatment to induce clinical remission in children with Crohn's disease (CD). However, the mechanism underlying the beneficial effects of...
4.
Campbell A, Gdanetz K, Schmidt A, Schmidt T
Microbiome . 2023 Jun; 11(1):133. PMID: 37322527
Background: Hydrogen gas (H) is a common product of carbohydrate fermentation in the human gut microbiome and its accumulation can modulate fermentation. Concentrations of colonic H vary between individuals, raising...
5.
Vasconcelos Pereira G, Boudaud M, Wolter M, Alexander C, De Sciscio A, Grant E, et al.
Res Sq . 2023 Mar; PMID: 36993463
Inflammatory bowel disease (IBD) is a chronic condition characterized by periods of spontaneous intestinal inflammation and is increasing in industrialized populations. Combined with host genetic predisposition, diet and gut bacteria...
6.
Ithman M, Sobule R, Kundert C, Campbell A, Ehrhardt E
Mo Med . 2022 Aug; 119(2):164-166. PMID: 36036039
Even though intravenous ketamine is not an FDA-approved depression treatment, multiple studies have shown a robust antidepressant effect which has led to an increase in clinical practices implementing its use...
7.
Pudlo N, Vasconcelos Pereira G, Parnami J, Cid M, Markert S, Tingley J, et al.
Cell Host Microbe . 2022 Mar; 30(3):314-328.e11. PMID: 35240043
Humans harbor numerous species of colonic bacteria that digest fiber polysaccharides in commonly consumed terrestrial plants. More recently in history, regional populations have consumed edible macroalgae seaweeds containing unique polysaccharides....
8.
Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D, et al.
Oncol Rev . 2021 Jul; 15(1):534. PMID: 34267890
Inactivating mutations of the () gene and consequential upregulation of the Wnt signaling pathway are critical initiators in the development of colorectal cancer (CRC), the third most common cancer in...
9.
Gopalakrishna G, Popoola O, Campbell A, Nemetalla M
J Addict Med . 2016 Feb; 10(2):131-3. PMID: 26900667
Substance abuse and dependence is estimated to cost roughly $700 billion annually including direct and indirect care in the United States. Drug dreams (DD), or using dreams, are a reportedly...
10.
Hofmann E, Webster J, Do T, Kline R, Snider L, Hauser Q, et al.
Bioorg Med Chem . 2016 Jan; 24(4):578-87. PMID: 26762836
In this study, we evaluated the abilities of a series of chalcones to inhibit the activity of the enzyme xanthine oxidase (XO) and to scavenge radicals. 20 mono- and polyhydroxylated...